𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Breastfeeding in inflammatory bowel disease: Positive results for mother and child

✍ Scribed by Judith Collins


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
46 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Nonadherence in inflammatory bowel disea
✍ Petr ČervenΓ½; Martin BortlΓ­k; AleΕ‘ KubΔ›na; JiΕ™Γ­ Vlček; Peter Laszlo Lakatos; Mil πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 2 views

## Background: The purpose of the study was to assess overall nonadherence to treatment among patients with crohn's disease (cd) and ulcerative colitis (uc) in a single tertiary center. ## Methods: A total of 177 patients were enrolled in this study (84 males, 93 females; 117 cd, 60 uc). patients

Medium-term results of oral tacrolimus t
✍ Siew C. Ng; Naila Arebi; Michael A. Kamm πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 2 views

## Background: This study aimed to evaluate the efficacy of oral tacrolimus in patients with inflammatory bowel disease (ibd) refractory to conventional therapy, including azathioprine, 6-mercaptopurine, and infliximab. ## Methods: Retrospective review of all patients with ibd treated with oral t

New proteomic approaches for biomarker d
✍ Giulia Roda; Alessandra Caponi; Marco Benevento; Paolo Nanni; Laura Mezzanotte; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 101 KB πŸ‘ 1 views

There is an increasing interest in the discovery of new inflammatory bowel disease (IBD) biomarkers able to predict the future patterns of disease and to help in diagnosis, treatment, and prognosis. A biomarker is a substance that can be measured biologically and is associated with an increased risk

Survival in cancer patients hospitalized
✍ Xiaochen Shu; Jianguang Ji; Jan Sundquist; Kristina Sundquist; Kari Hemminki πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 92 KB

## Background: The increased cancer risk among patients diagnosed with inflammatory bowel disease (ibd) is well reported, whereas studies regarding the cancer prognosis with ibd have shown conflicting results. we aimed at assessing and quantifying the cause-specific and overall mortality among canc